Inhibition of BRD4 expression attenuates the inflammatory response and apoptosis by downregulating the HMGB-1/NF-κB signaling pathway following traumatic brain injury in rats

[1]  V. Risbrough,et al.  Role of Inflammation in Traumatic Brain Injury–Associated Risk for Neuropsychiatric Disorders: State of the Evidence and Where Do We Go From Here , 2021, Biological Psychiatry.

[2]  Wei Li,et al.  Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus , 2021, Molecular medicine reports.

[3]  De-xiang Liu,et al.  Inhibiting Brd4 alleviated PTSD‐like behaviors and fear memory through regulating immediate early genes expression and neuroinflammation in rats , 2021, Journal of neurochemistry.

[4]  G. Sartor,et al.  BET bromodomains as novel epigenetic targets for brain health and disease , 2020, Neuropharmacology.

[5]  Han-dong Wang,et al.  Sodium aescinate provides neuroprotection in experimental traumatic brain injury via the Nrf2-ARE pathway , 2020, Brain Research Bulletin.

[6]  Xiaolong Yao,et al.  Astrocyte-derived exosomes enriched with miR-873a-5p inhibit neuroinflammation via microglia phenotype modulation after traumatic brain injury , 2019, Journal of Neuroinflammation.

[7]  Yang Gu,et al.  BRD4 suppression alleviates cerebral ischemia-induced brain injury by blocking glial activation via the inhibition of inflammatory response and pyroptosis. , 2019, Biochemical and biophysical research communications.

[8]  G. Roué,et al.  Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications , 2019, Cancers.

[9]  O. Franco,et al.  Epigenetics and Inflammatory Markers: A Systematic Review of the Current Evidence , 2019, International journal of inflammation.

[10]  Xiaolei Zhang,et al.  BRD4 inhibition attenuates inflammatory response in microglia and facilitates recovery after spinal cord injury in rats , 2019, Journal of cellular and molecular medicine.

[11]  Xiangrong Chen,et al.  Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3 , 2018, Journal of neuroinflammation.

[12]  O. Casasnovas,et al.  BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer , 2018, Biomedicines.

[13]  E. Ponomarev,et al.  Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation , 2018, Front. Immunol..

[14]  Tao Zhang,et al.  BRD4 has dual effects on the HMGB1 and NF-κB signalling pathways and is a potential therapeutic target for osteoarthritis. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[15]  H. Ni,et al.  Deletion of Mst1 attenuates neuronal loss and improves neurological impairment in a rat model of traumatic brain injury , 2017, Brain Research.

[16]  Shuixiang Deng,et al.  Glycyrrhizin Protects Rats from Sepsis by Blocking HMGB1 Signaling , 2017, BioMed research international.

[17]  Liang Sun,et al.  Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory phenotype , 2017, Journal of Neuroinflammation.

[18]  Mingcheng Huang,et al.  The suppression of bromodomain and extra‐terminal domain inhibits vascular inflammation by blocking NF‐κB and MAPK activation , 2017, British journal of pharmacology.

[19]  M. Weitzman,et al.  A core viral protein binds host nucleosomes to sequester immune danger signals , 2016, Nature.

[20]  O. Igwe,et al.  Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation. , 2015, Biochemical pharmacology.

[21]  R. Darnell,et al.  BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice , 2015, Nature Neuroscience.

[22]  J. Qi.  Bromodomain and extraterminal domain inhibitors (BETi) for cancer therapy: chemical modulation of chromatin structure. , 2014, Cold Spring Harbor perspectives in biology.

[23]  I. Adcock,et al.  Brd4 Is Essential for IL-1β-Induced Inflammation in Human Airway Epithelial Cells , 2014, PloS one.

[24]  K. Engelhard,et al.  Single Administration of Tripeptide α-MSH(11–13) Attenuates Brain Damage by Reduced Inflammation and Apoptosis after Experimental Traumatic Brain Injury in Mice , 2013, PloS one.

[25]  Ming-Ming Zhou,et al.  Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. , 2012, The Journal of Biological Chemistry.

[26]  D. Loane,et al.  Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention , 2012, Brain, Behavior, and Immunity.

[27]  K. Tracey,et al.  Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.

[28]  D. Sharp,et al.  Inflammation after trauma: Microglial activation and traumatic brain injury , 2011, Annals of neurology.

[29]  K. Tracey,et al.  HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.

[30]  Ewout W Steyerberg,et al.  Early prognosis in traumatic brain injury: from prophecies to predictions , 2010, The Lancet Neurology.

[31]  M. Chopp,et al.  Intravenous Administration of Human Umbilical Cord Blood Reduces Neurological Deficit in the Rat after Traumatic Brain Injury , 2002, Cell transplantation.

[32]  Y. Ye,et al.  Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes. , 2016, Rheumatology.

[33]  S. Vogel,et al.  Epigenetic Mechanisms Governing Innate Inflammatory Responses. , 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.